anastrozole has been researched along with Symptom Cluster in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a prospective study including postmenopausal early breast cancer patients receiving either an aromatase inhibitor (AI) or tamoxifen." | 3.77 | Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis. ( Christiaens, MR; De Smet, L; Dieudonné, AS; Henry, NL; Leunen, K; Lintermans, A; Morales, L; Neven, P; Pans, S; Paridaens, R; Timmerman, D; Van Calster, B; Van Hoydonck, M; Vergote, I; Verhaeghe, J; Verschueren, K; Westhovens, R; Wildiers, H, 2011) |
| "Women with breast cancer often experience multiple concurrent symptoms during AI therapy." | 1.51 | Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy. ( Bender, CM; Conley, YP; Li, H; Marsland, AL; Sereika, SM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Sereika, SM | 1 |
| Marsland, AL | 1 |
| Conley, YP | 1 |
| Bender, CM | 1 |
| Weiner, A | 1 |
| D'Andrea, GM | 1 |
| Coral-Casas, J | 1 |
| Ricaurte-Fajardo, A | 1 |
| McCormick, SJ | 1 |
| Baracaldo, I | 1 |
| Jimenez, CA | 1 |
| Mejia, JA | 1 |
| Lintermans, A | 1 |
| Van Calster, B | 1 |
| Van Hoydonck, M | 1 |
| Pans, S | 1 |
| Verhaeghe, J | 1 |
| Westhovens, R | 1 |
| Henry, NL | 1 |
| Wildiers, H | 1 |
| Paridaens, R | 1 |
| Dieudonné, AS | 1 |
| Leunen, K | 1 |
| Morales, L | 1 |
| Verschueren, K | 1 |
| Timmerman, D | 1 |
| De Smet, L | 1 |
| Vergote, I | 1 |
| Christiaens, MR | 1 |
| Neven, P | 1 |
4 other studies available for anastrozole and Symptom Cluster
| Article | Year |
|---|---|
Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy.
Topics: Aged; Anastrozole; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase | 2019 |
Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Liver Neoplas | 2018 |
[Reversible cerebral vasoconstriction syndrome associated with anastrozole: an unusual cause of high impact].
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Cerebrovascular Disorders; Female; Humans; Syndr | 2019 |
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis.
Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Arthralgia; Body Mass Index; Breast Neoplas | 2011 |